Atlas Trials

Open Study of the Neurobiological Effects of Intranasal Ketamine in Children and Adults With Bipolar Disorder

Clinical trial NCT05209217 · UNKNOWN

Trial details

NCT number
NCT05209217
Sponsor
Mclean Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Bipolar Disorder
Start date
2019-06-04
Primary completion
2022-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.